Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Sanofi (SNY) hired Alan Main as executive vice president of consumer healthcare, a business that is being reshaped into a new global unit. Most recently, he was global president of Bayer (BAYRY) Medical Care, and years ago, worked for Roche (RHHBY) Consumer Health.
Merck KGaA named Isabel De Paoli as chief strategy officer;
AstraZeneca (AZN) retained David Goldstein as chief adviser, genomics;
GlaxoSmithKline (GSK) named Brian McNamara as chief executive officer of its consumer health care division;
Karyopharm Therapeutics (KPTI) hired Humphrey Gardner as senior vice president, clinical development;
Nouscom hired Dr. Marina Udier Blagovic as chief operating officer;
Jounce Therapeutics (JNCE) hired Stephen Farrand as chief technical officer;
Epizyme (EPZM) hired Pamela Strode as vice president of regulatory affairs and quality assurance;
Neon Therapeutics (NTGN) hired Hugh O’Dowd as chief executive officer;
Abbott India hired Ambati Venu as managing director and general manager;
Bavarian Nordic hired Dr. Christopher Heery as chief medical officer;
Oticon hired Gary Rosenblum as president;
Idea Pharma added Mhairi Strachan as principal;
Prothena (PRTA) named Gene Kinney as interim chief executive officer while Dale Schenk is on medical leave;
Clinigen Group named Shaun Chilton as chief executive officer, replacing Peter George;
Assembly Biosciences (ASMB) hired Miguel Barbosa as chief scientific officer of its microbiome program;
Assembly Biosciences hired George Grandolfi as vice president of drug product and formulation;
Assembly Biosciences hired Christopher Hartnett as senior director of process development;
Assembly Biosciences hired Viktoria Gontcharova as principal scientist, bioinformatics;
Assembly Biosciences hired Christopher Howerton as senior director of strategy;
Assembly Biosciences hired Steven Cockrill as senior director, analytical development and quality control;